The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 04, 2022

Filed:

Oct. 26, 2018
Applicant:

Verily Life Sciences Llc, Mountain View, CA (US);

Inventors:

Nikhil Roy, Sunnyvale, CA (US);

Miguel Angelo Drumond, Oakland, CA (US);

Assignee:

Verily Life Sciences LLC, Mountain View, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G16H 20/17 (2018.01); A61B 5/00 (2006.01); A61B 5/145 (2006.01); A61B 5/11 (2006.01); H04L 51/02 (2022.01); G06F 40/30 (2020.01); G16H 20/10 (2018.01); G06V 10/70 (2022.01); H04W 88/02 (2009.01); G06Q 50/00 (2012.01);
U.S. Cl.
CPC ...
A61B 5/486 (2013.01); A61B 5/0022 (2013.01); A61B 5/0077 (2013.01); A61B 5/1112 (2013.01); A61B 5/1118 (2013.01); A61B 5/14532 (2013.01); A61B 5/4839 (2013.01); G06F 40/30 (2020.01); G06V 10/768 (2022.01); G16H 20/10 (2018.01); G16H 20/17 (2018.01); H04L 51/02 (2013.01); G06Q 50/01 (2013.01); H04W 88/02 (2013.01);
Abstract

The disclosed embodiments include a computer-implemented method for improving efficacy of diabetes self-management with automated personalized computer engagement that reliably obtains a measurement message and/or contextual information used to determine a suitable insulin dosage of an insulin titration process to treat the diabetic patient. The method includes causing display of a messaging interface that couples the user of the computing device to a chat bot simulating a health coach in a natural conversation to obtain a measurement of the diabetic patient's blood-glucose level. The method includes determining an insulin dosage recommendation to treat the diabetic patient by processing the measured blood-glucose level with an insulin titration algorithm that is personalized for the diabetic patient, and generating an electronic signal configured to cause a corresponding action to be performed by a computing device (e.g., display message of recommended insulin dosage).


Find Patent Forward Citations

Loading…